Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Willow

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Willow head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 251 · Grade C

Willow

Visit Willow Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Willow a bad call — it's best for people comparing treatment formats who will check the prescribed tier and renewal cutoff before enrolling. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
74
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
79
Track Record
88
73
CoreAge RxBrief Score 94 · 66Willow

Price, coverage & the tracker

CoreAge RxWillow
Brief Score94/100 (A)66/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$299/mo for listed standard injection tiers or sublingual tablet; higher injection tier listed at $399/mo

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

From $399/mo; listed injection tiers reach $549/mo and tablet tiers reach $459/mo

CoverageUS only; restrictions by state, confirmed at intake36 states listed by the provider; confirm your treatment and address
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Willow: Semaglutide is generally $299 per month, with a higher injection tier at $399; tirzepatide prices vary by formulation and dose. Check the prescribed tier and cancellation deadline before enrolling.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.